Fever/clinical signs and association with neutropenia in solid cancer patients - Bacterial infection as the main cause

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 5, 2010, Pages 1273-1277

  Hassan, Bassam Abdul Rasool ^a   Yusoff, Zuraidah Binti Mohd ^a   Othman, Saad Bin ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Clinical signs; Fever; Gram negative; Gram positive; Neutropenia; Onset; Severity

Indexed keywords

EID: 79955957178     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ammann RA, Aebi C, Hirt A, et al (2004). Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001. Support Care Cancer, 12, 826-32.
2. Bledsoe BE, Kufs D, Soltis CA (2005). Hematology. In: Bledsoe BE, Porter RS, Cherry RA, eds. Paramedic care/principles and practice. New Jersey: Pearson Prentice Hall, 458-289.
3. Dale DC (2005). Neutropenia. In: Herman NW, ed. Encyclopedia of Life Sciences. Chichester: John Wiley & Son's, Ltd., 147-63.
4. Flaherty J (1999). Infectious complications of oncology therapy. In: Vokes EE, Golomb HM, editors. Oncologic Therapies. Berlin: Springer, 228-44.
5. Frey RJ (1999). Neutropenia. In: Donna O, Christine J, Karen B, eds. The Gale Encyclopedia of Medicine. Farmington Hills: Gale Research, An International Thomson Company, 2057-9.
6. Frey R, Granger J (2002). Neutropenia. In: Thackery E, ed. The Gale Encyclopedia of Cancer. Detroit: Gale Group, 770-773.
7. Greene NG (2004). Composition of the normal microbial flora. In: Greene NG, ed. Infections in cancer patients. New York: Marcel Dekker, INC, 15-21.
8. Hughes WT, Armstrong D, Bodey GP, et al (2002). Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 34, 730-51.
9. Howland RD, Mycek MJ (2006). Pharmacology. Lippincot Williams & Wilkins, Philadelphia.
10. Jenson B (2003). Fever and neutropenia. Shiraz E-Medical J, 4, 1-16.
11. Klastersky J (2004). Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis, 39, 32-7.
12. Kern WV (2005). Current epidemiology of infections in neutropenic cancer patients. In: Rolston KVI, Rubenstein EB, eds. Textbook of febrile neutropenia. London: Martin Dunitz, 57-90.
13. Linker CA (2000). Blood. In: Tiernery LM, Mcphee SJ, Ppadakis MA, eds. Current Medical Diagnosis and Treatment. New York: Appleton & Lange, 499-551.
14. Lyman GH, Wilmot JP (2006). Risks and consequence of chemotherapy-induce neutropenia, Clinical Cornerstone, 8, 12-8.
15. Mitchell D (1999). Infections in cancer patients. In: Bishop JF, ed. Cancer Facts. Australia: Harwood Academic, 361-4.
16. Munshi HG (2000). Severe neutropenia: a diagnostic approach. Western j med, 172, 248-52.
17. Nuver J, Smit AJ, Van Der Meer J, et al (2005). Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. Clin Oncol, 23, 9130-7.
18. Rolston KVI (2001). Infections in patients with solid tumors. In: Rolston KVI, Rubenstein EB, eds. Text Book of Febrile Neutropenia. London: Martin Dunitz, Ltd., 91-109.
19. Schimpff SC (2001). Fever and neutropenia: an historical perspective. In: Rolston KVI, Rubenstein EB, eds. Text book of febrile neutropenia. London: Martin Dunitz, Ltd, 1-26.
20. Talcott JA, Rubenstein EB (2001). Initial clinical evaluation and risk assessment of the febrile neutropenic cancer patient. In: Rolston KVI, Rubenstein EB, eds. Text book of febrile neutropenia. London: Martin Dunitz Ltd., 50-165.
21. Wade JC (2001). Evaluation and management of fever in the neutropenic hematopoietic stem cell transplant patient. In: Rolston KVI, Rubenstein EB, eds. Text book of febrile neutropenia. London: Martin Dunitz, Ltd, 125-49.
22. Walker R, Edwards C (2003). Laboratory data. In: Wynne HA, Edward C, eds. Clinical Pharmacy & Therapeutics. New York: Churchill Livingstone, 47-65.